PHARMA PRODUCTION AS

1086 OSLO

Finances

Share Ownership

Return on Equity

−135,12 %

Current Ratio

1,26

Debt-to-Equity Ratio

Key figures (NOK)	2022	2021	2020	2019
Revenue	19 798 000	17 459 000	19 717 000	13 244 000
Net Income	−7 079 000	−5 350 000	−7 030 000	−6 277 000
Total Assets	23 618 000	11 343 000	18 934 000	7 766 000
Total Equity	5 239 000	317 000	317 000	−7 004 000

Income (NOK)	2022	2021	2020	2019
Revenue	19 798 000	17 459 000	19 717 000	13 244 000
Expenditure	26 238 000	22 254 000	24 295 000	21 430 000
Operating Profit	−6 439 000	−4 794 000	−4 578 000	−8 186 000
Financial Income	15 000	−7 000	41 000	9 000
Financial Costs	654 000	549 000	499 000	93 000
Financial Balance	−639 000	−556 000	−458 000	−84 000
Earnings Before Tax	−7 079 000	−5 350 000	−5 037 000	−8 270 000
Tax	0	0	1 993 000	−1 993 000
Net Income	−7 079 000	−5 350 000	−7 030 000	−6 277 000

Balance (NOK)	2022	2021	2020	2019
Total Fixed Assets	522 000	717 000	670 000	2 897 000
Total Current Assets	23 095 000	10 625 000	18 264 000	4 869 000
Total Assets	23 618 000	11 343 000	18 934 000	7 766 000
Total Retained Equity	4 922 000	1 000	0	−7 061 000
Total Equity	5 239 000	317 000	317 000	−7 004 000
Total Long-Term Debt	0	0	0	0
Total Current Debt	18 379 000	11 025 000	18 617 000	14 770 000
Total Equity and Debt	23 618 000	11 343 000	18 934 000	7 766 000

Cash flow (NOK)	2022	2021	2020	2019
Sales Income	19 798 000	17 459 000	19 717 000	13 244 000
Other Income	0	0	0	0
Revenue	19 798 000	17 459 000	19 717 000	13 244 000
Cost of Goods Sold	3 327 000	2 803 000	4 332 000	1 587 000
Salary Costs	9 804 000	8 505 000	9 326 000	7 559 000
Depreciation	278 000	304 000	266 000	262 000
Impairment	0	0	0	0
Expenditure	26 238 000	22 254 000	24 295 000	21 430 000
Operating Profit	−6 439 000	−4 794 000	−4 578 000	−8 186 000
Financial Income	15 000	−7 000	41 000	9 000
Financial Costs	654 000	549 000	499 000	93 000
Financial Balance	−639 000	−556 000	−458 000	−84 000
Dividends	0	0	0	0
Net Income	−7 079 000	−5 350 000	−7 030 000	−6 277 000

Balance details (NOK)	2022	2021	2020	2019
Goodwill	0	0	0	0
Total Intangible Assets	0	0	0	1 993 000
Real Eastate	195 000	391 000	586 000	781 000
Machinery and Plant Facilities	327 000	327 000	28 000	0
Fixtures	0	0	56 000	123 000
Total Tangible Assets	522 000	717 000	670 000	904 000
Total Fiancial Fixed Assets	0	0	0	0
Total Fixed Assets	522 000	717 000	670 000	2 897 000
Stock	2 265 000	2 348 000	742 000	420 000
Total Investments	0	0	0	0
Cash, Bank	265 000	253 000	683 000	203 000
Total Current Assets	23 095 000	10 625 000	18 264 000	4 869 000
Total Assets	23 618 000	11 343 000	18 934 000	7 766 000
Total Equity	5 239 000	317 000	317 000	−7 004 000
Short-Term Group Debt	15 378 000	8 541 000	10 558 000	0
Total Long-Term Debt	0	0	0	0
Creditors	238 000	412 000	367 000	2 453 000
Unpaid Taxes	526 000	484 000	570 000	878 000
Dividends	0	0	0	0
Other Current Debt	1 467 000	1 326 000	3 785 000	11 439 000
Total Current Debt	18 379 000	11 025 000	18 617 000	14 770 000
Total Equity and Debt	23 618 000	11 343 000	18 934 000	7 766 000

Financial indicators	2022	2021	2020	2019
Return on Equity	−135,12 %	−1 687,7 %	−2 217,67 %	89,62 %
Debt-to-Equity Ratio	0	0	0	−0
Operating Profit Margin	−32,52 %	−27,46 %	−23,22 %	−61,81 %
Current Ratio	1,26	0,96	0,98	0,33
Quick Ratio	1,43	1,22	1,02	0,34
Equity Ratio	0,22	0,03	0,02	−0,9
Gross Profit Margin	83,2 %	83,95 %	78,03 %	88,02 %